30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

AlloSource Enrolls in ProChondrix CR Study -

AlloSource enrolled the first patient in a prospective, multi-center study evaluating ProChondrix CR® fresh cryopreserved osteochondral allograft, for the repair of focal articular cartilage defects in the knee. AlloSource developed ProChondrix CR cartilage restoration therapy to provide live, functional cells, an intact extracellular matrix and other biological components for repair and regeneration of damaged cartilage. A two-year shelf life post-cryopreservation addresses the challenge of a short placement timeline, allowing more flexibility for hospitals and surgeons. (AlloSource, 3/20/19)